4/A
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-007111
Options or other derivatives
- Director acquired 39,475 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gumulka Jerzy · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-21 | Grant or award : show line 1 in the form Option to purchase common stock | +39,475 | 45,428 | D |
Loading xslF345X05/ownership.xml…